Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Available × Recurrence × Immunotherapy, Adoptive × Clear all

Status

Unknown 3 Recruiting 2 Not yet recruiting 2 Available 1 Active not recruiting 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Recurrence 1 Hematologic Neoplasms 1

Interventions

3-Iodobenzylguanidine 2 tisagenlecleucel 1 Immunotherapy, Adoptive 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04008524 2025-08-06

A Clinical Study of CAR-T Cells in the Treatment of Relapsed and Refractory Hematological Malignancies

Institute of Hematology & Blood Diseases Hospital, China

Other hematologic neoplasm

Recurrence, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡